| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | hexokinase activity | 6.81e-06 | 5 | 17 | 2 | GO:0004396 | |
| GeneOntologyMolecularFunction | fructokinase activity | 6.81e-06 | 5 | 17 | 2 | GO:0008865 | |
| GeneOntologyMolecularFunction | glucokinase activity | 6.81e-06 | 5 | 17 | 2 | GO:0004340 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 1.02e-05 | 6 | 17 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | D-glucose binding | 6.17e-05 | 14 | 17 | 2 | GO:0005536 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.04e-04 | 18 | 17 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 1.16e-04 | 310 | 17 | 4 | GO:0030246 | |
| GeneOntologyMolecularFunction | carbohydrate kinase activity | 1.42e-04 | 21 | 17 | 2 | GO:0019200 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 3.13e-04 | 31 | 17 | 2 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 3.55e-04 | 33 | 17 | 2 | GO:0005217 | |
| GeneOntologyMolecularFunction | monosaccharide binding | 2.91e-03 | 95 | 17 | 2 | GO:0048029 | |
| GeneOntologyMolecularFunction | calcium channel activity | 5.29e-03 | 129 | 17 | 2 | GO:0005262 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 6.20e-03 | 140 | 17 | 2 | GO:0099094 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 7.17e-03 | 151 | 17 | 2 | GO:0015085 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in mitochondrion | 6.38e-06 | 5 | 17 | 2 | GO:0072656 | |
| GeneOntologyBiologicalProcess | maintenance of location in cell | 5.08e-05 | 259 | 17 | 4 | GO:0051651 | |
| GeneOntologyBiologicalProcess | fructose 6-phosphate metabolic process | 7.62e-05 | 16 | 17 | 2 | GO:0006002 | |
| GeneOntologyBiologicalProcess | positive regulation of sequestering of calcium ion | 1.08e-04 | 19 | 17 | 2 | GO:0051284 | |
| GeneOntologyBiologicalProcess | canonical glycolysis | 1.33e-04 | 21 | 17 | 2 | GO:0061621 | |
| GeneOntologyBiologicalProcess | NADH regeneration | 1.33e-04 | 21 | 17 | 2 | GO:0006735 | |
| GeneOntologyBiologicalProcess | glucose catabolic process to pyruvate | 1.33e-04 | 21 | 17 | 2 | GO:0061718 | |
| GeneOntologyBiologicalProcess | carbohydrate phosphorylation | 1.90e-04 | 25 | 17 | 2 | GO:0046835 | |
| GeneOntologyBiologicalProcess | glycolytic process through glucose-6-phosphate | 1.90e-04 | 25 | 17 | 2 | GO:0061620 | |
| GeneOntologyBiologicalProcess | NAD catabolic process | 1.90e-04 | 25 | 17 | 2 | GO:0019677 | |
| GeneOntologyBiologicalProcess | maintenance of location | 2.61e-04 | 396 | 17 | 4 | GO:0051235 | |
| GeneOntologyBiologicalProcess | response to calcium ion | 2.93e-04 | 161 | 17 | 3 | GO:0051592 | |
| GeneOntologyBiologicalProcess | glycolytic process through fructose-6-phosphate | 2.93e-04 | 31 | 17 | 2 | GO:0061615 | |
| GeneOntologyBiologicalProcess | glucose catabolic process | 3.13e-04 | 32 | 17 | 2 | GO:0006007 | |
| GeneOntologyBiologicalProcess | glucose 6-phosphate metabolic process | 3.13e-04 | 32 | 17 | 2 | GO:0051156 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transporter activity | 4.65e-04 | 39 | 17 | 2 | GO:1901021 | |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | 5.23e-04 | 866 | 17 | 5 | GO:0055082 | |
| GeneOntologyBiologicalProcess | NADH metabolic process | 5.40e-04 | 42 | 17 | 2 | GO:0006734 | |
| GeneOntologyBiologicalProcess | maintenance of protein localization in organelle | 6.76e-04 | 47 | 17 | 2 | GO:0072595 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to organelle | 7.06e-04 | 515 | 17 | 4 | GO:0072594 | |
| GeneOntologyBiologicalProcess | hexose catabolic process | 8.60e-04 | 53 | 17 | 2 | GO:0019320 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | 9.23e-04 | 981 | 17 | 5 | GO:0019725 | |
| GeneOntologyBiologicalProcess | monosaccharide catabolic process | 9.94e-04 | 57 | 17 | 2 | GO:0046365 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | 1.49e-03 | 1091 | 17 | 5 | GO:0033365 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside triphosphate metabolic process | 1.51e-03 | 283 | 17 | 3 | GO:0009205 | |
| GeneOntologyBiologicalProcess | response to ischemia | 1.58e-03 | 72 | 17 | 2 | GO:0002931 | |
| GeneOntologyBiologicalProcess | ribonucleoside triphosphate metabolic process | 1.62e-03 | 290 | 17 | 3 | GO:0009199 | |
| GeneOntologyBiologicalProcess | purine nucleoside triphosphate metabolic process | 1.63e-03 | 291 | 17 | 3 | GO:0009144 | |
| GeneOntologyBiologicalProcess | NAD metabolic process | 1.71e-03 | 75 | 17 | 2 | GO:0019674 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in cell | 1.76e-03 | 76 | 17 | 2 | GO:0032507 | |
| GeneOntologyBiologicalProcess | nucleoside triphosphate metabolic process | 1.90e-03 | 307 | 17 | 3 | GO:0009141 | |
| GeneOntologyBiologicalProcess | embryonic heart tube morphogenesis | 1.95e-03 | 80 | 17 | 2 | GO:0003143 | |
| GeneOntologyBiologicalProcess | receptor metabolic process | 2.04e-03 | 82 | 17 | 2 | GO:0043112 | |
| GeneOntologyBiologicalProcess | cellular response to calcium ion | 2.35e-03 | 88 | 17 | 2 | GO:0071277 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transmembrane transporter activity | 2.56e-03 | 92 | 17 | 2 | GO:1901019 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | 2.71e-03 | 1249 | 17 | 5 | GO:0048878 | |
| GeneOntologyBiologicalProcess | positive regulation of ion transmembrane transporter activity | 2.84e-03 | 97 | 17 | 2 | GO:0032414 | |
| GeneOntologyBiologicalProcess | regulation of release of sequestered calcium ion into cytosol | 2.90e-03 | 98 | 17 | 2 | GO:0051279 | |
| GeneOntologyBiologicalProcess | embryonic heart tube development | 3.20e-03 | 103 | 17 | 2 | GO:0035050 | |
| GeneOntologyBiologicalProcess | positive regulation of transporter activity | 3.45e-03 | 107 | 17 | 2 | GO:0032411 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport | 3.57e-03 | 109 | 17 | 2 | GO:1904427 | |
| GeneOntologyBiologicalProcess | glycolytic process | 3.64e-03 | 110 | 17 | 2 | GO:0006096 | |
| GeneOntologyBiologicalProcess | maintenance of protein location | 3.77e-03 | 112 | 17 | 2 | GO:0045185 | |
| GeneOntologyBiologicalProcess | ADP catabolic process | 3.90e-03 | 114 | 17 | 2 | GO:0046032 | |
| GeneOntologyBiologicalProcess | purine nucleoside diphosphate catabolic process | 4.10e-03 | 117 | 17 | 2 | GO:0009137 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside diphosphate catabolic process | 4.10e-03 | 117 | 17 | 2 | GO:0009181 | |
| GeneOntologyBiologicalProcess | pyridine nucleotide catabolic process | 4.24e-03 | 119 | 17 | 2 | GO:0019364 | |
| GeneOntologyBiologicalProcess | ADP metabolic process | 4.31e-03 | 120 | 17 | 2 | GO:0046031 | |
| GeneOntologyBiologicalProcess | ribonucleoside diphosphate catabolic process | 4.38e-03 | 121 | 17 | 2 | GO:0009191 | |
| GeneOntologyBiologicalProcess | response to metal ion | 4.46e-03 | 415 | 17 | 3 | GO:0010038 | |
| GeneOntologyBiologicalProcess | tube development | 4.47e-03 | 1402 | 17 | 5 | GO:0035295 | |
| GeneOntologyBiologicalProcess | pyridine-containing compound catabolic process | 4.52e-03 | 123 | 17 | 2 | GO:0072526 | |
| GeneOntologyBiologicalProcess | nucleoside diphosphate catabolic process | 4.60e-03 | 124 | 17 | 2 | GO:0009134 | |
| GeneOntologyBiologicalProcess | small molecule catabolic process | 4.64e-03 | 421 | 17 | 3 | GO:0044282 | |
| GeneOntologyBiologicalProcess | disruption of cell in another organism | 4.96e-03 | 129 | 17 | 2 | GO:0141061 | |
| GeneOntologyBiologicalProcess | killing of cells of another organism | 4.96e-03 | 129 | 17 | 2 | GO:0031640 | |
| GeneOntologyBiologicalProcess | disruption of anatomical structure in another organism | 5.19e-03 | 132 | 17 | 2 | GO:0141060 | |
| GeneOntologyBiologicalProcess | purine nucleoside diphosphate metabolic process | 5.19e-03 | 132 | 17 | 2 | GO:0009135 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside diphosphate metabolic process | 5.19e-03 | 132 | 17 | 2 | GO:0009179 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to mitochondrion | 5.27e-03 | 133 | 17 | 2 | GO:0072655 | |
| Domain | Hexokinase_C | 7.79e-06 | 5 | 17 | 2 | IPR022673 | |
| Domain | Hexokinase_N | 7.79e-06 | 5 | 17 | 2 | IPR022672 | |
| Domain | Hexokinase_1 | 7.79e-06 | 5 | 17 | 2 | PF00349 | |
| Domain | HEXOKINASE_2 | 7.79e-06 | 5 | 17 | 2 | PS51748 | |
| Domain | Hexokinase_2 | 7.79e-06 | 5 | 17 | 2 | PF03727 | |
| Domain | Hexokinase_BS | 7.79e-06 | 5 | 17 | 2 | IPR019807 | |
| Domain | HEXOKINASE_1 | 7.79e-06 | 5 | 17 | 2 | PS00378 | |
| Domain | Hexokinase | 1.17e-05 | 6 | 17 | 2 | IPR001312 | |
| Domain | WD40 | 1.55e-03 | 259 | 17 | 3 | PF00400 | |
| Domain | WD40 | 1.71e-03 | 268 | 17 | 3 | SM00320 | |
| Domain | WD40_repeat | 1.79e-03 | 272 | 17 | 3 | IPR001680 | |
| Domain | WD_REPEATS_1 | 1.90e-03 | 278 | 17 | 3 | PS00678 | |
| Domain | WD_REPEATS_2 | 1.92e-03 | 279 | 17 | 3 | PS50082 | |
| Domain | WD_REPEATS_REGION | 1.92e-03 | 279 | 17 | 3 | PS50294 | |
| Domain | WD40_repeat_dom | 2.29e-03 | 297 | 17 | 3 | IPR017986 | |
| Domain | - | 3.17e-03 | 333 | 17 | 3 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 3.23e-03 | 335 | 17 | 3 | IPR015943 | |
| Domain | WD40_repeat_CS | 9.56e-03 | 164 | 17 | 2 | IPR019775 | |
| Domain | EF_HAND_2 | 1.83e-02 | 231 | 17 | 2 | PS50222 | |
| Domain | EF_hand_dom | 1.85e-02 | 232 | 17 | 2 | IPR002048 | |
| Domain | - | 2.30e-02 | 261 | 17 | 2 | 1.10.238.10 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_FIMA_TO_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS | 9.95e-06 | 6 | 12 | 2 | M47654 | |
| Pathway | WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS | 3.64e-05 | 11 | 12 | 2 | M48094 | |
| Pathway | KEGG_GALACTOSE_METABOLISM | 2.13e-04 | 26 | 12 | 2 | M4377 | |
| Pathway | KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM | 3.67e-04 | 34 | 12 | 2 | M15898 | |
| Pathway | WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION | 5.09e-04 | 40 | 12 | 2 | M39595 | |
| Pathway | WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER | 5.61e-04 | 42 | 12 | 2 | M45531 | |
| Pathway | KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM | 6.16e-04 | 44 | 12 | 2 | M8104 | |
| Pathway | WP_GLYCOLYSIS_AND_GLUCONEOGENESIS | 6.44e-04 | 45 | 12 | 2 | M39474 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 7.03e-04 | 47 | 12 | 2 | M19708 | |
| Pathway | WP_GLYCOLYSIS_AND_GLUCONEOGENESIS | 8.28e-04 | 51 | 12 | 2 | MM15928 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 8.60e-04 | 52 | 12 | 2 | M14171 | |
| Pathway | KEGG_GLYCOLYSIS_GLUCONEOGENESIS | 1.22e-03 | 62 | 12 | 2 | M11521 | |
| Pathway | PID_HIF1_TFPATHWAY | 1.38e-03 | 66 | 12 | 2 | M255 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 2.12e-03 | 82 | 12 | 2 | MM15394 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 2.28e-03 | 85 | 12 | 2 | M1870 | |
| Pathway | WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS | 2.33e-03 | 86 | 12 | 2 | M39375 | |
| Pathway | WP_METABOLIC_EPILEPTIC_DISORDERS | 2.61e-03 | 91 | 12 | 2 | M48079 | |
| Pathway | KEGG_INSULIN_SIGNALING_PATHWAY | 5.81e-03 | 137 | 12 | 2 | M18155 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 21504994 | ||
| Pubmed | Regulation of ryanodine receptor-dependent calcium signaling by polycystin-2. | 2.25e-07 | 2 | 17 | 2 | 17404231 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 24990892 | ||
| Pubmed | Effect of Increased IL-1β on Expression of HK in Alzheimer's Disease. | 6.74e-07 | 3 | 17 | 2 | 33525649 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 19049977 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 26855992 | ||
| Pubmed | Hexokinase regulates Bax-mediated mitochondrial membrane injury following ischemic stress. | 6.74e-07 | 3 | 17 | 2 | 21430642 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 20347420 | ||
| Pubmed | Fubp1 supports the lactate-Akt-mTOR axis through the upregulation of Hk1 and Hk2. | 6.74e-07 | 3 | 17 | 2 | 30871777 | |
| Pubmed | c-Src phosphorylation and activation of hexokinase promotes tumorigenesis and metastasis. | 6.74e-07 | 3 | 17 | 2 | 28054552 | |
| Pubmed | Direct neuronal glucose uptake heralds activity-dependent increases in cerebral metabolism. | 1.35e-06 | 4 | 17 | 2 | 25904018 | |
| Pubmed | Hexokinase activity is required for recruitment of parkin to depolarized mitochondria. | 1.35e-06 | 4 | 17 | 2 | 23962723 | |
| Pubmed | High 18F-FDG uptake in PMAH correlated with normal expression of Glut1, HK1, HK2, and HK3. | 1.35e-06 | 4 | 17 | 2 | 25766729 | |
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 32152094 | ||
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 15574336 | ||
| Pubmed | Hepatic glycogen synthesis in the absence of glucokinase: the case of embryonic liver. | 4.72e-06 | 7 | 17 | 2 | 18165236 | |
| Pubmed | The transcription factor Foxp1 regulates aerobic glycolysis in adipocytes and myocytes. | 6.29e-06 | 8 | 17 | 2 | 37150320 | |
| Pubmed | 8.08e-06 | 9 | 17 | 2 | 19554504 | ||
| Pubmed | 8.08e-06 | 9 | 17 | 2 | 21074528 | ||
| Pubmed | Proteomics identifies the developmental regulation of HKDC1 in liver of pigs and mice. | 1.01e-05 | 10 | 17 | 2 | 37545422 | |
| Pubmed | 1.15e-05 | 650 | 17 | 5 | 38777146 | ||
| Pubmed | Glucocorticoid receptor is required for foetal heart maturation. | 5.16e-05 | 22 | 17 | 2 | 23595884 | |
| Pubmed | Phosphoproteomics screen reveals akt isoform-specific signals linking RNA processing to lung cancer. | 8.44e-05 | 28 | 17 | 2 | 24462114 | |
| Pubmed | Characterising the dynamics of placental glycogen stores in the mouse. | 9.06e-05 | 29 | 17 | 2 | 32798765 | |
| Pubmed | Chronic Activation of γ2 AMPK Induces Obesity and Reduces β Cell Function. | 9.70e-05 | 30 | 17 | 2 | 27133129 | |
| Pubmed | 1.56e-04 | 38 | 17 | 2 | 38196272 | ||
| Pubmed | 1.56e-04 | 38 | 17 | 2 | 20185832 | ||
| Pubmed | A BMP-controlled metabolic/epigenetic signaling cascade directs midfacial morphogenesis. | 3.05e-04 | 53 | 17 | 2 | 38466355 | |
| Pubmed | 3.68e-04 | 730 | 17 | 4 | 34857952 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 4.70e-04 | 1425 | 17 | 5 | 30948266 | |
| Pubmed | An analysis of expression patterns of genes encoding proteins with catalytic activities. | 4.88e-04 | 67 | 17 | 2 | 17626619 | |
| Cytoband | 3q22.1 | 1.10e-04 | 42 | 17 | 2 | 3q22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q22 | 1.13e-03 | 135 | 17 | 2 | chr3q22 | |
| GeneFamily | WD repeat domain containing | 6.01e-04 | 262 | 12 | 3 | 362 | |
| GeneFamily | EF-hand domain containing | 8.90e-03 | 219 | 12 | 2 | 863 | |
| Coexpression | GSE17721_CTRL_VS_POLYIC_0.5H_BMDC_UP | 7.24e-06 | 200 | 17 | 4 | M3705 | |
| Coexpression | BASAKI_YBX1_TARGETS_DN | 1.07e-04 | 398 | 17 | 4 | M14877 | |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_UP | 1.62e-04 | 167 | 17 | 3 | M2995 | |
| Coexpression | MTOR_UP.N4.V1_DN | 2.15e-04 | 184 | 17 | 3 | M2756 | |
| Coexpression | SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP | 2.26e-04 | 484 | 17 | 4 | M14665 | |
| Coexpression | SEMENZA_HIF1_TARGETS | 2.46e-04 | 36 | 17 | 2 | M12299 | |
| Coexpression | GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_UP | 2.63e-04 | 197 | 17 | 3 | M3307 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_0.5H_BMDC_UP | 2.75e-04 | 200 | 17 | 3 | M3796 | |
| Coexpression | GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_UP | 2.75e-04 | 200 | 17 | 3 | M7980 | |
| Coexpression | GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN | 2.75e-04 | 200 | 17 | 3 | M6536 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_200 | 6.04e-06 | 155 | 17 | 4 | gudmap_developingGonad_e16.5_ovary_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#5_top-relative-expression-ranked_100 | 3.30e-05 | 11 | 17 | 2 | gudmap_developingGonad_e14.5_ epididymis_100_k5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_200 | 9.16e-05 | 18 | 17 | 2 | gudmap_developingGonad_e12.5_epididymis_k5_200 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#4_top-relative-expression-ranked_200 | 9.16e-05 | 18 | 17 | 2 | gudmap_developingGonad_P2_epididymis_200_k4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_200 | 1.26e-04 | 21 | 17 | 2 | gudmap_developingGonad_e14.5_ epididymis_200_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_100 | 1.38e-04 | 22 | 17 | 2 | gudmap_developingGonad_e16.5_epididymis_100_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_200 | 1.51e-04 | 23 | 17 | 2 | gudmap_developingGonad_e18.5_epididymis_200_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_200 | 1.94e-04 | 26 | 17 | 2 | gudmap_developingGonad_e18.5_ovary_200_k3 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_500 | 1.98e-04 | 379 | 17 | 4 | gudmap_developingGonad_P2_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500 | 2.04e-04 | 382 | 17 | 4 | gudmap_developingGonad_e14.5_ ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_200 | 2.06e-04 | 147 | 17 | 3 | gudmap_developingGonad_e18.5_ovary_200 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#1_top-relative-expression-ranked_200 | 2.09e-04 | 27 | 17 | 2 | gudmap_developingGonad_e16.5_ovary_200_k1 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | 2.14e-04 | 387 | 17 | 4 | gudmap_developingGonad_e18.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500 | 2.14e-04 | 387 | 17 | 4 | gudmap_developingGonad_e16.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_200 | 2.59e-04 | 159 | 17 | 3 | gudmap_developingGonad_e12.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | 3.09e-04 | 795 | 17 | 5 | gudmap_developingGonad_e16.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_top-relative-expression-ranked_1000 | 3.54e-04 | 819 | 17 | 5 | gudmap_developingGonad_e16.5_testes_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_1000 | 3.92e-04 | 837 | 17 | 5 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.10e-04 | 42 | 17 | 2 | gudmap_developingGonad_e12.5_testes_k2_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.00e-03 | 59 | 17 | 2 | gudmap_developingGonad_e16.5_testes_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_200 | 1.18e-03 | 64 | 17 | 2 | gudmap_developingGonad_e16.5_ovary_200_k5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#2_top-relative-expression-ranked_200 | 1.22e-03 | 65 | 17 | 2 | gudmap_developingGonad_e12.5_ovary_k2_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.28e-03 | 275 | 17 | 3 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_500 | 1.29e-03 | 67 | 17 | 2 | gudmap_developingGonad_e18.5_epididymis_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_100 | 1.33e-03 | 68 | 17 | 2 | gudmap_developingGonad_e12.5_ovary_100 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_200 | 1.37e-03 | 69 | 17 | 2 | gudmap_developingGonad_e11.5_ovary + mesonephros_k5_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.58e-03 | 74 | 17 | 2 | gudmap_developingGonad_e14.5_ testes_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#3_top-relative-expression-ranked_500 | 1.79e-03 | 79 | 17 | 2 | gudmap_developingGonad_P2_ovary_500_k3 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-07 | 173 | 17 | 4 | 8bffd512a4e561e23cc04478e2ca6fd5d3771fe4 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-07 | 173 | 17 | 4 | 3e3c61468e703330788a10d850ef41a85680f86d | |
| ToppCell | droplet-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-07 | 186 | 17 | 4 | 26f1e9930adf2fe4af0819e56f69915bd8330e4a | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.53e-05 | 153 | 17 | 3 | 5ac4b97d35c1029a5fc625239f92e35136c4d832 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 2.84e-05 | 159 | 17 | 3 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Stem_cells-neuroepithelial-like_cells|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 3.29e-05 | 167 | 17 | 3 | e488d9c7cf4355959e3833de3bd496c13fc11b1b | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.71e-05 | 174 | 17 | 3 | 8a8e98e62c2859c004b44dbce6974c9639ebeac6 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-Basophil/Mast_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.71e-05 | 174 | 17 | 3 | 31f7127faabcb1092bb9827db625f57cf7d8240e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 4.18e-05 | 181 | 17 | 3 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-05 | 187 | 17 | 3 | 91c8e93bde0d1d1a4e324b0acf2afda00f4fb3bf | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-immature_innate_lymphoid_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.60e-05 | 187 | 17 | 3 | fae08f34dc4b15352bd4d10bc6c924fe119b5d5e | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-immature_innate_lymphoid_cell-Ly6g5b+_T|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.60e-05 | 187 | 17 | 3 | e6b140b9fb582abf07aa6ea9bc437de3ba0d6de1 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-05 | 187 | 17 | 3 | 382db691eb0b3e089e816bed3d6699cc2d4e1bda | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.68e-05 | 188 | 17 | 3 | 8b1485e63cd4020ba5334a8d4b84725b164549bf | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-12|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.15e-04 | 112 | 17 | 2 | 96038a5240b89f2f6fd26ec5403ce1e23b01b266 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_B3-5|TCGA-Thymus / Sample_Type by Project: Shred V9 | 9.35e-04 | 120 | 17 | 2 | 9d4e630e1d3b9adf94a1884071bfe46edaa3f0c1 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.66e-04 | 122 | 17 | 2 | c7e81504e62d132624ec15b7d38dc5b6493a37a4 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.66e-04 | 122 | 17 | 2 | 8f675dc341b3f6e22f7e52c34d167d9e37df0982 | |
| ToppCell | TCGA-Prostate|World / Sample_Type by Project: Shred V9 | 9.81e-04 | 123 | 17 | 2 | 22b38555652b7a426a6277ed385361ae275310a3 | |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|kidney / Disease (COVID-19 only), tissue and cell type | 9.97e-04 | 124 | 17 | 2 | d6f59ddb9b9df02b5201f23fa5fb78f3fd891ee9 | |
| ToppCell | droplet-Skin-nan-18m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-03 | 125 | 17 | 2 | 5a309ce803d2b8efd791eb21808121bf5fc3ea8e | |
| ToppCell | COVID-19-kidney-Mito-rich_Int|kidney / Disease (COVID-19 only), tissue and cell type | 1.08e-03 | 129 | 17 | 2 | 57b705106aec7bbfc587de1ccd4f2335fc44dd6f | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-03 | 130 | 17 | 2 | e5acaa9aaa22b10d11410e2c01647b31354c21ed | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-03 | 130 | 17 | 2 | 4c8b931987432e8bcd39029d4fa124dc383ea355 | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-03 | 132 | 17 | 2 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.18e-03 | 135 | 17 | 2 | c4d3c9eba2a85ac40fea5ecfcc2b442a472323d0 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-03 | 138 | 17 | 2 | e2659949944bdf39b23c7275e380a7a937e2726c | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-03 | 138 | 17 | 2 | d5342383c5e52b92c39d7afe76560501be3ea5cd | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Whrn_Tox2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.32e-03 | 143 | 17 | 2 | 36ce6f163fb33141c86288086c354b91853fad25 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 1.38e-03 | 146 | 17 | 2 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 1.42e-03 | 148 | 17 | 2 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-03 | 148 | 17 | 2 | 7c7c87b57aa16f8b91698489df39ace5a3a53df8 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-03 | 149 | 17 | 2 | defe2e4a2f3118f8b42e99a4f2bf03e54c1b698f | |
| ToppCell | PND07-Immune-Immune_Myeloid-Granulocytic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.53e-03 | 154 | 17 | 2 | f92d83c5f8b532fe5624f1cd352632f543d96ea9 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.55e-03 | 155 | 17 | 2 | e1a20e88b9c0eaf7ca7004acc0eda096d1588563 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-03 | 156 | 17 | 2 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-03 | 157 | 17 | 2 | ec433d2fe827abdb647be4176c231b7052482b6f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-03 | 157 | 17 | 2 | bfec34182f052cf1c0d847ba53ea335d4d1190de | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Hsd11b1_Endou|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.61e-03 | 158 | 17 | 2 | c8af8964a140acb2987e3b4906d72c546108d229 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_3|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.61e-03 | 158 | 17 | 2 | 0559cc032d0b518bb9e55aa3495f5573bd8e87dd | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-03 | 161 | 17 | 2 | b9a17f41426bf715f30bf544a6795afaf37a3aa6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-03 | 161 | 17 | 2 | a7e09cf2ca6cd70d40d08440fe9c5ab9befa1b79 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-03 | 161 | 17 | 2 | b9a63fc9becc44d305fc7c221283bf59ec06b10f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-03 | 161 | 17 | 2 | 08920a716f6ec62538e361211455a30ad726d7be | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-03 | 161 | 17 | 2 | f7a89c481f789f624102857be722c95fbeb47595 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic-Basophil|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.73e-03 | 164 | 17 | 2 | dc22b1fef49c1557a0b63c536eaba574dfcab715 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Mast_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-03 | 164 | 17 | 2 | 2c48c6e4eeee845f0563982d0bfa2a176ca5ef61 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.73e-03 | 164 | 17 | 2 | f4de9f18134a06f3d7fcf5b50b8e21c1506e2083 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibrocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-03 | 165 | 17 | 2 | 8a52f2dbcbd2bc1662b5e3fac381463fdcc3bf14 | |
| ToppCell | ILEUM-non-inflamed-(4)_Mast|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.80e-03 | 167 | 17 | 2 | de0cb257def6049830af068f8f74829a708b810f | |
| ToppCell | ILEUM-non-inflamed-(4)_Mast_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.80e-03 | 167 | 17 | 2 | 85b39e05eb6e18e06b47e374d808e479ca65173c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5-6_RORB_LINC00320|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.80e-03 | 167 | 17 | 2 | b0b2601c41c053b1caa6701ba2f5723e6059fb0a | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-03 | 167 | 17 | 2 | 3c06894fc6177f3c204094719904da42f08b9af8 | |
| ToppCell | facs-Aorta-Heart-24m-Myeloid-leukocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-03 | 167 | 17 | 2 | b85fd7ab21c80470bca804c788ce49a2bce763f8 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.82e-03 | 168 | 17 | 2 | c7021748003e5949f7caf7b3291c5bad294948c1 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-03 | 168 | 17 | 2 | 784ce773521e5d74570f45120e56d112bc76ff49 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.84e-03 | 169 | 17 | 2 | c6e5b179461996ced6c7621dc01cec00d401f4e8 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-03 | 170 | 17 | 2 | 7a4ed69c807c3761210776e8fe6680d1bd892e82 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-03 | 170 | 17 | 2 | 749144a1a869a6bf9acdd227184319083367dc3f | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial-N_cells_(NTS+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.86e-03 | 170 | 17 | 2 | 02f0be0aab8ba2d35a83238609352ef3677511c9 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Granulocytic-Basophil|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.86e-03 | 170 | 17 | 2 | bca78719c17355772ad6c53ee75e459faf1d089f | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-03 | 170 | 17 | 2 | 25d60a62e8f99c31ab64fe6a0c07ccca3df1a7ee | |
| ToppCell | PND07-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.86e-03 | 170 | 17 | 2 | 40d863554ec98ae43f76511c1112859688846613 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 1.88e-03 | 171 | 17 | 2 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.88e-03 | 171 | 17 | 2 | 5e93c76ee60f9d0590ebb140812653a5e1369417 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-5|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.88e-03 | 171 | 17 | 2 | 23b3120706bb9c20b9214fe3760c6d7a84f1e749 | |
| ToppCell | normal_Lung-B_lymphocytes-Undetermined|B_lymphocytes / Location, Cell class and cell subclass | 1.88e-03 | 171 | 17 | 2 | f49dfe11ae66d82125b577c48345a13683d7bb7b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.88e-03 | 171 | 17 | 2 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | ILEUM-inflamed-(4)_Mast|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.90e-03 | 172 | 17 | 2 | be82f749f4b1049ae8832facc052082cf5463c11 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.90e-03 | 172 | 17 | 2 | c05af6e559f6af0fb15cefa03ffa1413e98a1a4a | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-Regulatory_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-03 | 172 | 17 | 2 | d824e46c8040b0bb9235f9b8a2b35386b303caa0 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-03 | 172 | 17 | 2 | 1ef243bce63d841c25e4b74d029d1377f84bcc3d | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-03 | 172 | 17 | 2 | b3c53fd7e50f36de6a8585ae21d04e17932f262c | |
| ToppCell | P07-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.90e-03 | 172 | 17 | 2 | 8d6a2a0d5f63b09a5a304a77e600a647f87e9de4 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Basophil|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.90e-03 | 172 | 17 | 2 | 953b05f776348cff784e79c93df65841939d880f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-03 | 172 | 17 | 2 | ab1c81be29f93ca8920c6ab5ab92f497a9256d3f | |
| ToppCell | Immune_cells-B_cell|Immune_cells / Lineage and Cell class | 1.90e-03 | 172 | 17 | 2 | b646894b691a99bf2742bd9da8e578dff0e87f1f | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-03 | 172 | 17 | 2 | 1b133be191252e7053faeacf9547730c3ae28d21 | |
| ToppCell | ILEUM-inflamed-(4)_Mast_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.90e-03 | 172 | 17 | 2 | 7185b28282412f3a464b2a8ad5605475a1a31358 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-03 | 172 | 17 | 2 | e680abead2da75e50774da02384eb2729c839c01 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-regulatory_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-03 | 172 | 17 | 2 | 10a1d1838492b8ce6dea08844353b51571432c56 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-03 | 173 | 17 | 2 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-03 | 173 | 17 | 2 | f612d4ea9ab8dcde475f4118bca3e49be786e7fa | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-03 | 173 | 17 | 2 | c62e3ffed55bbb00dcaef6da0aab8446f3f55085 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic-Basophil|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.92e-03 | 173 | 17 | 2 | 8ca650542655c27516029e5bace97ff1b9dcc256 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-03 | 173 | 17 | 2 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-03 | 173 | 17 | 2 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.92e-03 | 173 | 17 | 2 | 4282b47b33325472f52a4085986988911a372ed8 | |
| ToppCell | 3'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_mucus_secreting_cell-SMG_mucous-SMG_mucous_L.0.6.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.95e-03 | 174 | 17 | 2 | b1b54e4e23df8cfc04bf298d5c53de203a38b267 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-CD45|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-03 | 175 | 17 | 2 | 16cf0c5d3d009480e07e8fe78c0f8555c2d6e3df | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-03 | 175 | 17 | 2 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-03 | 176 | 17 | 2 | c6484334187f64cd00cd35e77d8ae436556b4260 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.99e-03 | 176 | 17 | 2 | 2e1003dc373b14d27f0464d980453fdcfc1005f0 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-03 | 176 | 17 | 2 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-03 | 176 | 17 | 2 | 66c9c6b59030f67e8d746a9c6930e50923f2ded1 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-03 | 176 | 17 | 2 | b4a23d8d1414434adeb237a96f28c825f1aebd77 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.01e-03 | 177 | 17 | 2 | 95760841b3f085d38c4926b258a33563d93a2016 | |
| ToppCell | RSV-Healthy-4|RSV / Virus stimulation, Condition and Cluster | 2.04e-03 | 178 | 17 | 2 | a5835951492c051443f3c30d45f9a7b1b2557477 | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-B_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-03 | 178 | 17 | 2 | 5b6f7e8a930c239db1f31edfb61b2b9228d28663 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-6_RORB_HPCA|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.04e-03 | 178 | 17 | 2 | f2766913de010b718ba3799996d658b8f499adc5 | |
| Drug | galactosone | 1.92e-07 | 16 | 17 | 3 | CID000097398 | |
| Drug | 2,5-anhydro-D-mannitol | 1.53e-06 | 31 | 17 | 3 | CID000001494 | |
| Drug | N-bromoacetylglucosamine | 3.15e-06 | 4 | 17 | 2 | CID000152920 | |
| Drug | 2,3-anhydro-D-allose | 3.15e-06 | 4 | 17 | 2 | CID000191595 | |
| Drug | 1,5-anhydroglucitol 6-phosphate | 3.15e-06 | 4 | 17 | 2 | CID003081444 | |
| Drug | 1-deoxy-D-manno-heptulose | 3.15e-06 | 4 | 17 | 2 | CID000193198 | |
| Drug | lofenal | 3.15e-06 | 4 | 17 | 2 | CID000159256 | |
| Drug | AC1L5VHN | 3.15e-06 | 4 | 17 | 2 | CID000235938 | |
| Drug | 3-chloromethylthiochromone-1,1-dioxide | 5.24e-06 | 5 | 17 | 2 | CID000100620 | |
| Drug | 2-fluoro-2-deoxy-6-phosphogluconate | 5.24e-06 | 5 | 17 | 2 | CID000127270 | |
| Drug | 8-thiocyano-ATP | 7.86e-06 | 6 | 17 | 2 | CID000132196 | |
| Drug | glucose 6-arsenate | 1.10e-05 | 7 | 17 | 2 | CID000128033 | |
| Drug | AC1L5A5F | 1.10e-05 | 7 | 17 | 2 | CID000173497 | |
| Drug | AFDG | 1.47e-05 | 8 | 17 | 2 | CID000164297 | |
| Drug | tetrahydropyran-2-methanol | 1.47e-05 | 8 | 17 | 2 | CID000007524 | |
| Drug | AC1O5S5Y | 1.47e-05 | 8 | 17 | 2 | CID006439672 | |
| Drug | dimethyl suberimidate | 1.68e-05 | 68 | 17 | 3 | CID000034750 | |
| Drug | ATP-EDC | 2.35e-05 | 10 | 17 | 2 | CID000195647 | |
| Drug | first rate | 2.87e-05 | 11 | 17 | 2 | CID000086453 | |
| Drug | triethyltin bromide | 4.07e-05 | 13 | 17 | 2 | CID000017701 | |
| Drug | glutamate | 4.64e-05 | 962 | 17 | 6 | CID000000611 | |
| Drug | isotetrandrine | 4.88e-05 | 97 | 17 | 3 | CID000005422 | |
| Drug | AC1Q6HGX | 5.48e-05 | 15 | 17 | 2 | CID000000600 | |
| Drug | palmitoylcarnitine | 5.67e-05 | 102 | 17 | 3 | CID000000461 | |
| Drug | morpholine-citrate | 7.97e-05 | 18 | 17 | 2 | CID000173845 | |
| Drug | bromopyruvate | 7.97e-05 | 18 | 17 | 2 | ctd:C017092 | |
| Drug | AC1NBU2S | 8.53e-05 | 117 | 17 | 3 | CID004473765 | |
| Drug | o-toluidine | 9.89e-05 | 20 | 17 | 2 | CID000007242 | |
| Drug | NSC 226836 | 9.89e-05 | 20 | 17 | 2 | CID000012600 | |
| Drug | acadesine | 1.06e-04 | 126 | 17 | 3 | CID000017513 | |
| Drug | 2-deoxy-D-glucose 6-phosphate | 1.09e-04 | 21 | 17 | 2 | CID000440992 | |
| Drug | GDP-Man | 1.45e-04 | 140 | 17 | 3 | CID000000732 | |
| Drug | St. Thomas' Hospital cardioplegic solution | 1.51e-04 | 142 | 17 | 3 | ctd:C041711 | |
| Drug | 2-deoxy-2-fluoro-D-talose | 1.69e-04 | 26 | 17 | 2 | CID000068614 | |
| Drug | isocitrate | 2.00e-04 | 156 | 17 | 3 | CID000001198 | |
| Drug | ATP beta S | 2.11e-04 | 29 | 17 | 2 | CID000123766 | |
| Drug | mg U | 2.25e-04 | 30 | 17 | 2 | CID000445508 | |
| Drug | AICAR monophosphate | 2.28e-04 | 163 | 17 | 3 | CID000000200 | |
| Drug | acetylphenylhydrazine | 2.41e-04 | 31 | 17 | 2 | CID000008247 | |
| Drug | AP2PL | 2.41e-04 | 31 | 17 | 2 | CID000121867 | |
| Drug | lavendustin A | 2.62e-04 | 171 | 17 | 3 | CID000003894 | |
| Drug | lonidamine | 2.73e-04 | 33 | 17 | 2 | CID000039562 | |
| Drug | CNS 1145 | 2.73e-04 | 33 | 17 | 2 | CID000190902 | |
| Drug | IHC-64 | 2.73e-04 | 33 | 17 | 2 | CID000162753 | |
| Drug | 3-OMG | 2.73e-04 | 33 | 17 | 2 | CID000097217 | |
| Drug | bromoacetic acid | 2.73e-04 | 33 | 17 | 2 | CID000006226 | |
| Drug | 2-deoxy-D-arabino-hexose 6-phosphate | 2.90e-04 | 34 | 17 | 2 | CID000108108 | |
| Drug | beta-hydroxybutyrate | 3.00e-04 | 179 | 17 | 3 | CID000000441 | |
| Drug | AC1L9IGO | 3.25e-04 | 184 | 17 | 3 | CID000445722 | |
| Drug | riboxin | 3.26e-04 | 36 | 17 | 2 | CID000006831 | |
| Drug | mag-fura-2 | 3.44e-04 | 37 | 17 | 2 | CID000123839 | |
| Drug | creatine | 3.74e-04 | 193 | 17 | 3 | CID000000586 | |
| Drug | Corticosterone [50-22-6]; Down 200; 11.6uM; HL60; HT_HG-U133A | 3.79e-04 | 194 | 17 | 3 | 1307_DN | |
| Drug | Nalidixic acid sodium salt hydrate; Down 200; 14.6uM; HL60; HT_HG-U133A | 3.85e-04 | 195 | 17 | 3 | 2336_DN | |
| Drug | Nitrarine dihydrochloride [20069-05-0]; Up 200; 10.6uM; PC3; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 3683_UP | |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 1541_DN | |
| Drug | Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 2845_DN | |
| Drug | Iopamidol [60166-93-0]; Up 200; 5.2uM; PC3; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 5832_UP | |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 5533_DN | |
| Drug | AC1L1AH5 | 5.12e-04 | 215 | 17 | 3 | CID000000986 | |
| Drug | AC1L1IM7 | 5.33e-04 | 46 | 17 | 2 | CID000004638 | |
| Drug | AC1Q6RZL | 5.56e-04 | 47 | 17 | 2 | CID000001144 | |
| Drug | ts M | 5.80e-04 | 48 | 17 | 2 | CID000428025 | |
| Drug | CID5288005 | 5.80e-04 | 48 | 17 | 2 | CID005288004 | |
| Drug | hexadecanal | 5.92e-04 | 226 | 17 | 3 | CID000000984 | |
| Drug | glycerol-3-phosphate | 5.92e-04 | 226 | 17 | 3 | CID000000754 | |
| Drug | glucitol-6-phosphate | 6.04e-04 | 49 | 17 | 2 | CID000000618 | |
| Drug | FT T | 6.55e-04 | 51 | 17 | 2 | CID000445622 | |
| Drug | 3-bromopyruvate | 6.81e-04 | 52 | 17 | 2 | CID000070684 | |
| Drug | AC1L494B | 7.07e-04 | 53 | 17 | 2 | CID000181487 | |
| Drug | 18F-FDG | 7.07e-04 | 53 | 17 | 2 | CID000315411 | |
| Drug | AC1L1DKE | 7.61e-04 | 55 | 17 | 2 | CID000002388 | |
| Drug | DB07744 | 7.61e-04 | 55 | 17 | 2 | CID011840941 | |
| Drug | Ptpc | 7.61e-04 | 55 | 17 | 2 | CID003036276 | |
| Drug | Cinildipine | 7.89e-04 | 56 | 17 | 2 | CID000002752 | |
| Drug | AC1Q6RZ6 | 9.05e-04 | 60 | 17 | 2 | CID000000609 | |
| Drug | [(2S)-2-[(Z)-dodec-9-enoyl]oxy-3-tetradecanoyloxypropyl] [(2R,3R,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl] phosphate | 9.05e-04 | 60 | 17 | 2 | CID011968289 | |
| Drug | nilvadipine | 9.05e-04 | 60 | 17 | 2 | CID000004494 | |
| Drug | IAA-94 | 9.36e-04 | 61 | 17 | 2 | CID000003667 | |
| Drug | 2-ethoxyethanol | 9.36e-04 | 61 | 17 | 2 | ctd:C021296 | |
| Drug | carnitine | 9.39e-04 | 265 | 17 | 3 | CID000000085 | |
| Drug | AC1Q6S1V | 9.98e-04 | 63 | 17 | 2 | CID000000620 | |
| Drug | lercanidipine | 9.98e-04 | 63 | 17 | 2 | CID000065866 | |
| Drug | 1,6-di-o-phosphonohexopyranose | 1.03e-03 | 64 | 17 | 2 | CID000000737 | |
| Drug | gallopamil | 1.13e-03 | 67 | 17 | 2 | CID000001234 | |
| Disease | Cognitive impairment | 1.71e-05 | 11 | 17 | 2 | HP_0100543 | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 1.17e-04 | 28 | 17 | 2 | DOID:4194 (implicated_via_orthology) | |
| Disease | Myocardial Ischemia | 1.33e-04 | 176 | 17 | 3 | C0151744 | |
| Disease | multiple myeloma (is_implicated_in) | 5.24e-04 | 59 | 17 | 2 | DOID:9538 (is_implicated_in) | |
| Disease | atrophic macular degeneration, age-related macular degeneration, wet macular degeneration | 5.42e-04 | 60 | 17 | 2 | EFO_0001365, EFO_0004683, EFO_1001492 | |
| Disease | acute lymphoblastic leukemia | 6.56e-04 | 66 | 17 | 2 | EFO_0000220 | |
| Disease | Malignant Glioma | 7.37e-04 | 70 | 17 | 2 | C0555198 | |
| Disease | mixed gliomas | 7.37e-04 | 70 | 17 | 2 | C0259783 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 9.61e-04 | 80 | 17 | 2 | DOID:6432 (biomarker_via_orthology) | |
| Disease | Glioma | 1.14e-03 | 87 | 17 | 2 | C0017638 | |
| Disease | obesity (is_implicated_in) | 1.24e-03 | 91 | 17 | 2 | DOID:9970 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RGEKYMGMWQDDVCQ | 1171 | Q96Q42 | |
| MGMWQDDVCQGNGVV | 1176 | Q96Q42 | |
| QMWERMDEGCGETIY | 81 | O00178 | |
| EGGENGPWMRFMRAE | 81 | Q6JQN1 | |
| WVRDGILVVGMDCEM | 1221 | Q9Y485 | |
| GTQDGIMAVWDMEEQ | 886 | Q149M9 | |
| DEGRMCINMEWGAFG | 251 | P52789 | |
| VEGEEGRMCVNMEWG | 696 | P52789 | |
| GEDCVMMRGSGRWND | 256 | P06734 | |
| VEGDQGQMCINMEWG | 696 | P19367 | |
| RWQEDGGVMIIGYEM | 1671 | P46100 | |
| MEIWGGENVEMSFRV | 376 | Q8NCL4 | |
| EMRGAMEGKQVQWEC | 251 | Q96A23 | |
| EMFGDEEVMCLNGNW | 181 | Q03591 | |
| WQAGDVVGCMVDMNE | 1156 | Q92736 | |
| GNNEVSMWDMETGDR | 1206 | Q99570 | |
| EEGGMVVEMDVEWRP | 106 | Q13563 | |
| EWMDYGCAQEAEGRM | 341 | Q8IUK5 | |
| DDEMGCTWGMGEDAV | 331 | Q9BWU0 |